We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.72T
| $2.17B | 4.98% |
15,902,654
-291,900
| -2% | -$44.2M |
|
2
Microsoft
MSFT
$2.83T
| $2.04B | 4.67% |
7,933,843
+12,800
| +0.2% | +$3.47M |
|
3
Amazon
AMZN
$2.51T
| $967M | 2.22% |
9,106,660
-35,000
| -0.4% | -$4.38M |
|
|
4
Royalty Pharma
RPRX
$26.2B
| $702M | 1.61% |
16,707,815
-8,134,900
| -33% | -$333M |
|
5
Alphabet (Google) Class A
GOOGL
$3.89T
| $682M | 1.56% |
6,261,400
-22,000
| -0.4% | -$2.59M |
|
|
6
Alphabet (Google) Class C
GOOG
$3.89T
| $628M | 1.44% |
5,740,220
-62,000
| -1% | -$7.33M |
|
|
7
ExxonMobil
XOM
$650B
| $587M | 1.35% |
6,859,215
-2,681,600
| -28% | -$242M |
|
8
Tesla
TSLA
$1.26T
| $570M | 1.31% |
2,537,700
+349,200
| +16% | +$95.3M |
|
9
UnitedHealth
UNH
$385B
| $502M | 1.15% |
976,406
-7,100
| -0.7% | -$3.57M |
|
10
Berkshire Hathaway Class B
BRK.B
$1.06T
| $492M | 1.13% |
1,800,357
-15,677
| -0.9% | -$4.92M |
|
|
BHVN
11
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $443M | 1.02% |
3,039,092
+2,849,092
| +1,500% | +$364M |
|
12
Johnson & Johnson
JNJ
$624B
| $390M | 0.89% |
2,195,975
+87,380
| +4% | +$15.6M |
|
13
NVIDIA
NVDA
$5.06T
| $386M | 0.88% |
25,448,110
-4,000
| -0% | -$75.5K |
|
14
Procter & Gamble
PG
$342B
| $385M | 0.88% |
2,677,873
+234,800
| +10% | +$35.3M |
|
15
Meta Platforms (Facebook)
META
$1.54T
| $385M | 0.88% |
2,387,035
-24,200
| -1% | -$4.67M |
|
|
16
Textron
TXT
$16.2B
| $378M | 0.87% |
6,190,951
+1,566,489
| +34% | +$103M |
|
17
Burlington
BURL
$21.4B
| $365M | 0.84% |
2,681,030
+355,170
| +15% | +$64.3M |
|
18
Eli Lilly
LLY
$1.06T
| $362M | 0.83% |
1,116,668
+133,910
| +14% | +$40.2M |
|
19
ConocoPhillips
COP
$146B
| $315M | 0.72% |
3,504,864
-1,052,907
| -23% | -$108M |
|
|
20
Dollar Tree
DLTR
$22.6B
| $306M | 0.7% |
1,966,238
-1,460,500
| -43% | -$231M |
|
21
Mastercard
MA
$469B
| $302M | 0.69% |
958,810
+33,200
| +4% | +$11.4M |
|
22
Home Depot
HD
$324B
| $293M | 0.67% |
1,069,206
+233,750
| +28% | +$69M |
|
23
Pfizer
PFE
$143B
| $285M | 0.65% |
5,439,601
-1,168,000
| -18% | -$59.5M |
|
|
HES
24
DELISTED
Hess
HES
| $270M | 0.62% |
2,548,118
-500,682
| -16% | -$56.6M |
|
25
Coca-Cola
KO
$349B
| $249M | 0.57% |
3,955,582
+296,200
| +8% | +$18.8M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.